Default Category
-
Merck: La administración de Vioxx (D)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-111S05Knowledge and CommunicationStarting at €5.74
-
Pfizer: Letter from the Chairman (B)
Simons, Robert L.; Rosenberg, KathrynCase HBS-110004-EAccounting and ControlThis case continues the story begun in "Pfizer: A Letter From The Chairman" (HBS No. 9-110-003), revealing the letter Chairman and CEO Jeff Kindler wrote for the 2008 Annual Report.Starting at €5.74
-
Pfizer: Letter from the Chairman (A) and (B), Teaching Note
Simons, Robert L.; Rosenberg, KathrynTeaching Note HBS-110067-EAccounting and ControlTeaching Note for 110003 and 110004.Starting at €0.00
-
Eve Hall: The African American Investment Fund in Milwaukee, Teaching Note
Rogers, Steven S.; Mills, AlterrellTeaching Note HBS-318008-EEntrepreneurshipTeaching note for case 317076.Starting at €0.00
-
John Rogers and Ariel Investments, Teaching Note
Rogers, Steven S.; White, GregTeaching Note HBS-318016-ETeaching note for case 318015.Starting at €0.00
-
John Rogers, Jr. - Ariel Investments Co., Teaching Note
Rogers, Steven S.; White, GregTeaching Note HBS-318100-ETeaching note for case 318099.Starting at €0.00
-
Fairview Capital
Rogers, Steven S.; Collins, DerrickCase HBS-319050-EEntrepreneurshipFairview Capital is a pioneering alternative assets investment manager, as it is the first U.S. private equity fund of funds that focused on investing in private equity and venture capital funds managed by African-Americans and other minority investment managers. This case study focuses on Fairview's strategic decisions that ultimately led to the growth and expansion of its investment portfolio to over $3 billion.Starting at €8.20
-
Managing Vioxx (A) (Spanish version)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-111S02Strategy(B) evidence of life-threatening side effects, (C) decision options, (D) announcement to withdraw Vioxx, (E) reaction by patients, shareholders, media, and regulators, (F) Merck fights back, and (G) wrap-up. At the end of the case series, students may conclude that doing the right thing sometimes requires very hard choices.Starting at €8.20
-
Merck: La administración de Vioxx (B)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-111S03Knowledge and CommunicationStarting at €5.74
-
Merck: La administración de Vioxx (C)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-111S04Knowledge and CommunicationStarting at €5.74